Abstract IGF-1 receptor (IGF-1R) and integrin cooperative signaling promotes cancer cell survival, proliferation, and motility, but whether this influences cancer progression and therapy responses is largely unknown. Here we investigated the non-receptor tyrosine adhesion kinase FES-related (FER), following its identification as a potential mediator of sensitivity to IGF-1R kinase inhibition in a functional siRNA screen. We found that FER and the IGF-1R co-locate in cells and can be coimmunoprecipitated. Ectopic FER expression strongly enhanced IGF-1R expression and phosphorylation on tyrosines 950 and 1131. FER phosphorylated these sites in an IGF-1R kinase-independent manner and also enhanced IGF-1-mediated phosphorylation of SHC, and activation of either AKT or MAPK-signaling pathways in different cells. The IGF-1R, β1 Integrin, FER, and its substrate cortactin were all observed to co-locate in cell adhesion complexes, the disruption of which reduced IGF-1R expression and activity. High FER expression correlates with phosphorylation of SHC in breast cancer cell lines and with a poor prognosis in patient cohorts. FER and SHC phosphorylation and IGF-1R expression could be suppressed with a known anaplastic lymphoma kinase inhibitor (AP26113) that shows high specificity for FER kinase. Overall, we conclude that FER enhances IGF-1R expression, phosphorylation, and signaling to promote cooperative growth and adhesion signaling that may facilitate cancer progression.
Introduction
The insulin-like growth factor-1 receptor (IGF-1R) and its signaling pathway have a well-described function in sustaining a transformed phenotype [1] [2] [3] [4] . Igf-1r knockout (Igf-1r −/− ) mouse derived fibroblasts are refractory to transformation by oncogenes [3] . The phosphorylated receptor recruits IRS-1, IRS-2, or SHC to activate signaling pathways that promote cell survival, proliferation, or motility [1, 5] . However, despite compelling evidence for IGF-1R activity in facilitating cancer progression, efforts to target the IGF-1R in cancer have resulted in poor efficacy and clinical response [2, 6, 7] . Many reasons have been proposed for this, including observations that expression of IGF ligands and IGF-1R may not always correlate with signaling activity [7] [8] [9] [10] . This has confounded the identification of useful biomarkers for IGF-1R activity inhibition in cancer cells.
Others and we have previously established that IGF-1R kinase activity and signaling output are modulated by adhesion-associated protein complexes [2, 5, 11] . This cross-talk contributes to the mitogenic, migratory, and invasive phenotype of breast, lung, cervical, and prostate cancer [11] [12] [13] [14] . Indeed, β1 Integrin ligation enhances IGF-1R surface expression and localization to sites of focal adhesion in prostate cancer cells [11] . A complex of IGF-1R with β1 Integrin that includes the scaffolding protein RACK1 and focal adhesion kinase, promotes MAPK pathway activity [5, 15] . Furthermore, adhesion-activated kinases SRC and FAK can directly phosphorylate IGF-1R in vitro and enhance IGF-1R-induced invasiveness of breast Sandra O'Shea and Orla Cox Joint authorship.
cancer cells [12, 14, 16, 17] . All of these observations indicate that the recruitment of the IGF-1R to adhesion complexes can significantly modify IGF-1R activation and signaling. However, it is not known whether adhesion signals are essential for IGF-1R activity in cancer progression or therapy responses.
We addressed this question by screening for proteins that modulate the cytotoxic response to IGF-1R tyrosine kinase inhibition using a functional siRNA screen [18] . We identified the non-receptor tyrosine FES-related (FER) kinase as a mediator of sensitivity to the IGF-1R tyrosine kinase inhibitor, BMS-754807, in MCF-7 cells. FER, along with FES, belongs to a distinct subfamily of receptor tyrosine kinases that possess FES/CIP4 homology BinAmphiphysin-Rvs (F-BAR) domains [19] . FER activity has been described in several cancers, including lung, hepatic, prostate, and breast and is reported to facilitate tumorigenesis and chemoresistance by enhancing cell migration, invasion and proliferation [20] [21] [22] [23] . FER has been shown to interact with the EGFR, PDGFR, FLT3, and c-MET [21, [24] [25] [26] and proposed to facilitate cross-talk between growth factor receptors and cell-cell or cell-matrix adhesion complexes [19] .
In this study, we investigated whether FER modulates IGF-1R signaling in different cell lines. We found that FER associates with and enhances IGF-1R expression and activity at the plasma membrane and sites of cell adhesion. FER significantly increases IGF-1R phosphorylation on key tyrosines to enhance IGF-1-mediated activation of SHC and MAPK pathways in an adhesion-dependent manner. We conclude that FER kinase is an important modulator of IGF-1R activity in cancer cells. This may be particularly important in mesenchymal or migratory cancer cells where cooperative growth factor and adhesion signaling could facilitate cancer progression.
Results

FER associates with and enhances IGF-1R expression levels
We identified FER as a modifier of responses to IGF-1R kinase inhibition in an siRNA screen [18] , which suggested that FER may modulate IGF-1R activity. A previous study using peptide libraries identified FER as a kinase that could phosphorylate specific tyrosines in the Insulin and IGF-1 Receptors [27] . Both of these observations suggested that FER could modulate IGF-1R activity. To investigate this we first tested whether FER and the IGF-1R interact. Using proximity ligation assays (PLA) with anti-FER and anti-IGF-1R antibodies, we observed that FER and IGF-1R are clearly found in proximity in MCF-7 cells (Fig. 1a) . FER could also Fig. 1 FER associates with IGF-1R and enhances expression levels. a Proximity ligation assay (PLA) showing protein interaction between FER and IGF-1R in MCF-7 cells. Cells were cultured on coverslips, fixed, and probed with one of two rabbit anti-IGF-1R antibodies (#3027, top panels or #9750, bottom panels) and mouse anti-FER antibody (#4268), and then subjected to PLA as described in the methods section. Negative controls are cells without primary antibody subjected to PLA. Slides were examined by confocal microscopy using a Zeiss LSM700 inverted confocal microscope equipped with a × 60 oil-immersion objective, numerical aperture 1.4. Z-projected images of the collected Z-stack were performed and analyzed using the Olympus Fluoview software. Each white spot (red in merged images) represents a single interaction. The presented images are maximum intensity projections of Z-stacks acquired from a representative of three independent experiments. b Western blot analysis of coimmunoprecipitated IGF-1R and FER. The IGF-1R was immunoprecipitated from R + cells that were serum-starved (−), stimulated with IGF-1 (10 min; 10 ng/ml; + ), or stimulated with IGF-1 in the presence of BMS-754807 (BMS). Beads-and-lysates (B&L) and beads-andantibody (B&A) controls were included as well as cell lysates from the immunoprecipitation inputs. Blots were probed with anti-IGF-1R and anti-FER antibodies. The panel underneath shows the levels of P-1135/ 1136 IGF-1R and P-AKT in total lysates used for immunoprecipitation (as controls for BMS-754807 inhibition of IGF-1R kinase activity). c Western blot analysis of IGF-1R and FER co-immunoprecipitated from HEK293T cells. The IGF-1R was immunoprecipitated from cells that were transfected with plasmids encoding IGF-1R wild type (IGF-1R/WT (pcDNA3)), FER (WT (pSG5-FER)), FER/Kinase Dead (FER/ KD; D743R mutant), an SH2-domain mutant of FER (R483Q; SH2), or corresponding empty vector plasmids (EV), 48 h post transfection. Beads-and-lysates (B&L) and beads-and-antibody (B&A) controls were included as well as the immunoprecipitation inputs. The panel below shows the levels of FER and IGF-1R in cell lysates used for immunoprecipitation. d, e FER enhances IGF-1R protein expression levels. HEK293T cells were co-transfected with empty vector (pcDNA3-EV; EV, x-axis on graph) or IGF-1R/WT (IGF-1R, x-axis on graph) plus either empty vector (pSG5-EV; EV, black bars on graph) or FER/WT (FER, gray bars on graph). Cells were lysed and immunoblotted for determination of IGF-1R and FER protein expression with β actin as a loading control d. mRNA expression of igf-1r was assessed by RT-qPCR using igf-1r-specific primers with Ubiquitin C (UBC) as a control to normalize mRNA levels e. The graphs show densitometry measurements of the average fold difference ± SEM in IGF-1R protein expression: d, or average fold change difference ± SEM in igf-1r mRNA expression: e, in FERoverexpressing cells compared with EV controls. Data are from n ≥ 3 independent experiments, a two-way ANOVA with Bonferroni test was applied. f Expression of IGF-1R WT and KD are both enhanced by FER. Western blots were prepared with cell lysates from HEK293T cells (40 h post transfection) expressing either Empty Vector (pcDNA3; EV), IGF-1R/WT or Vector encoding IGF-1R/ Kinase Dead (KD; K1003R mutant), as well as either empty vector (pSG5; EV) or FER. The blots were probed with anti-IGF-1R or anti-FER antibodies with β actin as a loading control. The graph represents densitometry measurements of average fold difference in IGF-1R protein expression ± SEM in cells expressing EV, IGF-1R/WT, or KD, together with EV or FER from four independent experiments. Twoway ANOVA with Bonferroni test was applied. g FER kinase activity is not required for FER-mediated increased expression of IGF-1R. After 40 h of transfection, HEK293T cells expressing empty vector (pcDNA3; EV), IGF-1R/WT, or IGF-1R/KD and/or empty vector control for FER (pSG5; EV), FER, or FER/KD, were lysed and immunoblotted IGF-1R and FER expression. Densitometry measurements of mean ± SEM fold-difference in IGF-1R protein expression from three independent experiments. A one-way ANOVA with Bonferroni test was applied be co-immunoprecipitated with the IGF-1R from R + cells (mouse embryonic fibroblasts derived from igf-1r −/− mouse with IGF-1R re-expressed) (Fig. 1b) . This was evident in cells that were serum deprived or stimulated with IGF-1, and in the presence of an IGF-1R kinase inhibitor BMS-754807 that suppressed IGF-1R autophosphorylation and IGF-induced activation of AKT (Fig. 1b bottom panel) . The IGF-1R and FER could also be co-immunoprecipitated from HEK293T cells that were co-transfected with IGF-1R and either wild type FER (WT), kinase-inactive FER (KD), or a SH2-domain mutant of FER (R483Q) (Fig. 1c) . Interestingly, in these experiments it was noted that levels of IGF-1R expression were apparently higher in cells transfected with FER than in vector-expressing controls. We further tested the effects of FER on IGF-1R expression in HEK293T cells. Co-transfection of plasmids encoding FER and the IGF-1R resulted in a sixfold increase in IGF-1R protein levels compared with levels in cells transfected with IGF-1R and vector controls (Fig. 1d ). This increase in protein was not owing to enhanced transcription because Igf-1r mRNA expression levels were lower in cells expressing FER than in controls (Fig. 1e) .
To test whether FER kinase activity was required to enhance IGF-1R protein levels, we transiently expressed IGF-1R in the presence of either FER/WT or FER/KD in HEK293T cells. Both FER/WT and FER/KD enhanced IGF-1R protein levels (Fig. 1f) . Furthermore, levels of both IGF-1R/WT and kinase-dead IGF-1R (IGF-1R/KD) could be increased by co-transfection with FER (Fig. 1g) . Taken together, these data indicate that FER and IGF-1R associate in different cells, and that FER enhances IGF-1R protein expression and steady state levels in a manner that is not dependent on either IGF-1R or FER kinase activity.
FER enhances phosphorylation of the IGF-1R and its signaling output
We next investigated whether FER influences IGF-1R phosphorylation and kinase activity by co-expressing FER with either IGF-1R/WT or IGF-1R/KD in HEK23T cells. We observed that FER expression specifically enhanced phosphorylation on Y950 (in the juxtamembrane region) and on Y1131 (in the kinase activation loop) on both IGF-1R/WT and IGF-1R/KD (Fig. 2a) . Thus, IGF-1R kinase activity is not necessary for FER-enhanced phosphorylation of the Y950 and Y1131 sites. Phosphorylation of Y1135/ 1136 site in the kinase activation loop was evident with IGF-1R/WT, in the presence of FER, but not with kinaseinactive IGF-1R/KD (Fig. 2a) , indicating that phosphorylation on this site by FER is dependent on IGF-1R activity.
To exclude the possibility that the effects of FER on phosphorylation of IGF-1R/KD were due to endogenous, albeit low, levels of IGF-1R expression in HEK293T cells, we carried out similar experiments in R− cells. We observed that co-expression of FER with IGF-1R WT or KD also enhanced phosphorylation on Y950 and Y1131. Again, FER did not enhance phosphorylation on the Y1135/ 1136 site in IGF-1R/KD (Fig. 2b) . To test whether enhanced phosphorylation of the IGF-1R by FER required FER kinase activity, we co-expressed the IGF-1R/WT or IGF-1R/KD with either FER or FER/KD. These experiments demonstrated that enhanced phosphorylation of IGF-1R (WT or KD) on Y950 and Y1131 was observed in both serum-starved and IGF-1-stimulated cells. This was entirely dependent on an active FER kinase because the kinaseinactive FER/KD did not enhance IGF-1R phosphorylation (Fig. 2c) .
As FER enhances phosphorylation of the IGF-1R independently of IGF-1R kinase activity, we next asked whether this phosphorylation enhances IGF-1 signaling responses. Ectopic FER expression in HEK293T cells did not alter IGF-1-stimulated activation of the PI3-K pathway, as measured by phosphorylation of AKT on S473 (Fig. 2d) . This is likely resulting from the high basal levels of AKT phosphorylation present in HEK293T cells that are not reduced by serum starvation, with no further response to IGF-1 stimulation. However, basal levels of SHC and FAK phosphorylation are low in these cells, which is consistent with their relatively weak adhesion to the substratum. Overexpression of FER/WT, but not FER/KD, significantly increased both basal and IGF-1-stimulated phosphorylation of SHC and ERK1/2 (Fig. 2d) . Importantly, in vector control cells, IGF-1 did not induce detectable phosphorylation of Y239/240 on SHC, but IGF-1-induced phosphorylation on these sites was evident in the presence of FER. Phosphorylation of FAK (Y397 and Y925) and SRC (Y416) . Cells were lysed 48 h after transfection and western blots were prepared to assess levels of P-Y950, P-Y1131, P-Y1135/ 1136, and total IGF-1R. The levels of total FER were assessed as a control for transfection efficiency. Densitometry measurements of mean ± SEM fold-difference in specific P-Y site as indicated on the xaxis based on at n = 3 independent experiments; Two-way ANOVA with Bonferroni test. c Western blotting analysis of IGF-1R phosphorylation in HEK293T cells co-overexpressing: EV, FER, or FER/ KD with IGF-1R/WT (WT) or IGF-1R/KD (KD). At 48 h post transfection, cells were serum starved for 4 h, IGF-1 stimulated (10 min; 10 ng/ml; + ) and subsequently lysed for western blots to assess levels of P-Y950, P-Y1131, P-Y1135/1136, and total IGF-1R. FER levels were assessed as a control for transfection efficiency. d Western blotting analysis of IGF-1-mediated downstream signaling pathways in HEK293T cells co-overexpressing: EV, FER, or FER/KD with IGF-1R/WT (WT) or IGF-1R/KD (KD). At 48 h post transfection, cells were serum starved for 4 h prior to IGF-1 stimulation (10 min; 10 ng/ml; + ). Western blots were prepared to assess levels of P-SHC (Y239/Y240), P-FAK (Y397, Y925), P-SRC (Y416), and P-AKT (S473). The levels of total FER were assessed as a control for transfection efficiency. Densitometry measurements of mean ± SEM average fold difference in specific P-Y proteins/total protein levels as indicated above the graph, based on n ≥ 3 independent experiments. Statistical analysis was performed using two-way ANOVA with Bonferroni test were also significantly enhanced by IGF-1 in FER/WT− but not in FER/KD-expressing cells (Fig. 2d) .
Overall these data demonstrate that FER enhances phosphorylation of specific autophosphorylation sites on the IGF-1R in a FER kinase-dependent but IGF-1R kinaseindependent manner. This is associated with enhanced IGF-1-signaling responses.
FER, IGF-1R, and β1 integrin associate in adhesion complexes that enhance FER activity
The IGF-1R has previously been demonstrated to participate in a signaling complex with β1 Integrin to promote cell proliferation and motility [5, 15] . FER has also been reported to regulate β1 integrin signaling [28] , so we hypothesized that FER is a component of a signaling complex containing Integrin and IGF-1R. In agreement with our observations in Fig. 1 from PLA and immunoprecipitation, we observed that FER and IGF-1R strongly co-localize by co-immunofluorescence in MCF-7 cells (Fig. 3a) . Furthermore, as shown by confocal microscopy the majority of surface IGF-1R in these cells is present at large complexes that also contain FER and β1 Integrin (Fig. 3b) and vinculin (Fig. S1 ). These complexes represent sites of focal cell adhesion. In MDA-MB-231 cells FER and the IGF-1R were also both observed to co-localize with β1 integrin at distinct sites of cell protrusion and adhesion (Fig. 3c) .
We next asked whether an activated IGF-1R affects FER kinase activity, by measuring FER autophosphorylation on Y402 in HEK293T cells transfected with empty vector, IGF-1R/WT or IGF-1R/KD. IGF-1 strongly promoted FER autophosphorylation in vector-expressing cells, which indicates that activation of endogenous IGF-1R is sufficient to enhance FER activity. FER autophosphorylation was further increased in cells expressing IGF-1R/WT but not in cells expressing IGF-1R/KD (Fig. 3d ), thus confirming a requirement for activated IGF-1R in FER activation. Overexpression of FER/WT but not KD in HEK293T cells increased the phosphorylation of SHC (P-Y239/240) and ERK1/2 (P-T202/Y204) without any evident effect on phosphorylation of AKT (Fig. 3e) . FER/WT also promoted a significant increase in phosphorylation of the focal adhesion-associated kinases SRC (Y416) and FAK (on both Y397 and Y925) (Fig. 3f) .
Taken together, these results demonstrate that FER and the IGF-1R are components of β1 Integrin-anchored adhesion complexes that enhance activation and autophosphorylation of FER in an adhesion-and IGF-1-dependent manner. This suggests that the association of the IGF-1R with FER enhances cooperative IGF and adhesion signaling via the SHC, FAK and MAPK pathways and that these receptors may reciprocally activate each other.
FER suppression reduces IGF-1R expression and proliferation, and differentially affects cell migration
Having observed clear effects of FER on enhancing IGF-1R expression, phosphorylation, and signaling we next asked whether suppression of FER would alter IGF-1R expression and activity. To do this, we first screened a panel of siRNAs that specifically target FER in different breast cell lines (Fig.  S2A ). We observed a consistent suppression of FER with all siRNAs tested (except siFER4). IGF-1R expression levels were clearly reduced by most of these siRNAs in MCF-7, MDA-MB-231 cells, and HS578T cells and MCF10A cells (Fig. S2A ). To investigate this further we focused on two siRNAs (siFER2 which suppressed IGF-1R significantly and siFER3 which suppressed IGF-1R to a lesser extent) to further examine the effects of FER suppression on IGF-1R expression in all four cell lines. Both siFER2 and 3 substantially decreased IGF-1R protein levels at 48 h post transfection in MCF-7, MDA-MB-231 and HS578T cells (Fig. 4a) , whereas β1 Integrin levels were largely unaffected ( Fig. 4a and Fig. S2B ). Similar effects were observed with MCF10A cells at 48 h (Fig. S2D ) and for all cell lines at 72 h post siRNA transfection ( Fig. S2C and D).
We next investigated the effects of siFER2 and 3 on IGF-1 signaling in MCF-7 and MDA-MB-231 cells. In MCF-7 cells FER suppression had no effect on IGF-1-induced AKT phosphorylation, but both siRNAs clearly reduced IGF-1- Fig. 3 FER, IGF-1R, and β1 integrin associate in adhesion complexes that enhance FER activity. a-b Co-localization of IGF1R with β1 integrin and FER with β1 integrin. Confocal images of MCF-7 cells grown for 24 h on coverslips and co-stained for FER (red) and IGF-1R (rabbit antibody, green; a) β1 integrin (red) and IGF-1R (mouse antibody, green; upper panels, b) and FER (red) and β1 integrin (green; lower panels, b) using antibodies described in methods. Colocalization is shown by the overlap of the fluorescent labels appearing in yellow. Cells were photographed using an Olympus Fluoview FV1000 confocal laser scanning microscope, and Z-stacks were acquired and analyzed using Fluoview Olympus software. At least two slices were acquired at different Z positions (Z1-Z2). Zoomed images (a, b) are presented in their respective Z-planes. Individual slices were 0.5-μm. Scale represents 20 μm. c MDA-MB-231 were grown on coverslips coated with 5 μg/cm 2 collagen I for 24 h and immunofluorescence staining was performed. IGF-1R (mouse, Millipore) and β1-Integrin (rabbit, green) are shown in the upper panels and FER (mouse) and β1-Integrin (rabbit, green) shown in the lower panels. A yellow signal depicts areas of co-localization of the red and green fluorescent labels. The nuclei were stained with Hoechst (blue). Original 40 × magnification, scale bars represent 200 µm. d FER phosphorylation is enhanced by cell adhesion. At 40 h post-plasmid DNA transfection, HEK293T cells expressing EV, IGF-1R/WT or IGF-1R/ KD were serum-starved for 4 h and stimulated with IGF-1 (10 min; 10 ng/ml; + ), lysed and immunoblotted for P-Y402 FER/ FER. P-AKT and P-ERK1/2 were used as IGF-1 signaling controls. Densitometry measurements of mean ± SEM average fold difference in P-Y402 FER in the above conditions based on three independent experiments; twoway ANOVA with Bonferroni test. e, f Western blotting analysis of EV, FER/WT, or FER/KD overexpressing HEK293T cells. 48 h post DNA transfection, cells were lysed and immunoblotted for the indicated phospho-and total protein levels. Densitometry measurements of mean ± SEM average fold difference in specific P-Y proteins/total protein levels as indicated on the y-axis in the described above conditions based on n ≥ 3 independent experiments. One-way ANOVA with Bonferroni test was applied stimulated phosphorylation of ERK1/2 ( Fig. 4b) . In MDA-MB-231 cells phosphorylation of ERK1/2 is generally not responsive to serum withdrawal or IGF-1, but IGF-1 induces strong phosphorylation of AKT. Here FER suppression with both siRNAs reduced IGF-1-induced phosphorylation of AKT (Fig. 4b) . These data indicate that FER suppression can suppress IGF-1 signaling responses. In line with this we observed that cell proliferation rates in MCF-7 and MDA-MB-231 cell lines were suppressed by both siFER2 and siFER3 (Fig. 4c) .
We next investigated the migratory potential of MDA-MB-231 cells in Transwells with FER suppressed by siFER2 and siFER3. Surprisingly, we observed that siFER2 partially suppressed directional migration towards serum (approximately 30%) while siFER3 greatly impaired cell migration (by~80%) (Fig. 4d) . Interestingly, we noted that the morphology of cells transfected with either siFER2 or siFER3 was quite different (siFER2 caused cells to become more spread while siFER3 caused cells to become more spindle-like). These differences in morphology elicited by siFER2 and 3 were consistently and reproducibly observed in all cell lines transfected with these siRNAs (MCF-7, MDA-MB-231, HS578T, and MCF10A cells) (Fig. S2E) . MDA-MB-231 cell adhesion to fibronectin was impaired by siFER3, but not by siFER2 (Fig. 4e) . Thus, our data show that similar levels of FER suppression can result in different effects on cell morphology and migratory potential. Although we cannot explain these consistently different siRNA effects, the data suggest they may be related to suppressing essential FER function in the formation of dynamic cell adhesion structures, such as lamellipodia, which are necessary for cell migration.
Overall, we conclude that suppression of FER can reduce IGF-1R levels, IGF-1 signaling and cell proliferation. The data also indicate that similar suppression of FER does not correlate with similar effects on IGF-1R expression or cell phenotype, and FER suppression may result in different effects on cell morphology and migratory potential.
Co-location of IGF-1R with FER in adhesion complexes enhances IGF-1R activity
Next, we sought to investigate whether FER is required for IGF-1R activity in adhesion complexes. First, we investigated the effects of FER suppression with siFER2 and siFER3 on the association of IGF-1R and FER with β1 Integrin in MDA-MB-231 cells. In agreement with our observations on cell morphology (Fig. S2E) , we observed that cells transfected with siFER2 were more spread with fewer directional lamellipodia, while cells transfected with siFER3 were elongated and spindle-like (Fig. 5a, b) . Although IGF-1R could be observed to co-localize with β1 integrin in adhesion complexes in control siNEG cells (Fig.  5a top panels), as described for Fig 3a, b, these structures and IGF-1R/β1 Integrin co-localization were less evident in cells with FER suppressed (Fig 5a, b, c) . As expected FER levels were suppressed by siFER2 and 3, and less association with β1 Integrin was also observed (Fig. 5b) . In MCF-7 cells transfected with siFER2, cell adhesion sites appeared to be smaller and less mature with considerably less vinculin, β1 integrin and IGF-1R present (Fig. S2A-C) . These immature adhesion sites were especially evident upon confocal imaging of siFER2-transfected cells that were stained for paxillin (Fig. S3B) . Taken together, these data indicate that suppression of FER with either siFER2 or Fig. 4 Suppression of FER with siRNA suppresses IGF-1R activity and cell proliferation, but variably affects migratory potential. a Suppression of FER with siRNAs affects IGF-1R levels: Protein expression of the indicated proteins was analyzed by immunoblotting in control (siNEG) cells and cells transfected with two different FER siRNAs (siFER2 or 3), 48 h post transfection. Graphs show densitometry measurements of mean fold difference ± SEM of IGF-1R expression in siFER-transfected cells compared with siNEG controls, from at least n = 3 independent experiments; Statistical analysis was performed using two-way ANOVA with Bonferroni test. b Western blot analysis of IGF-1R downstream signaling in cells with FER suppressed: At 48 h post transfection with siNEG or siFER, MCF-7, and MDA-MB-231 cells were serum starved for 4 h prior to stimulation with IGF-1 (10 ng/ml), for indicated times. Cell lysates were assessed by SDS-PAGE and immunoblotting for expression of FER, IGF-1R, P-AKT, P-ERK and non-phospho controls. Graphs of mean fold difference ± SEM of P-ERK and P-AKT expression are shown, quantified by densitometry from three independent experiments. Statistical significance was analyzed by two-way ANOVA with Bonferroni test. c FER suppression causes decreased cell proliferation: At 24 h post transfection with siNEG or siFER, cells were plated in triplicate at the same cell number and fixed and stained with crystal violet every 24 h for a further 96 h. Staining intensity at each timepoint was analyzed using an Odyssey scanner and densitometric measurements from three separate experiments ± SEM are shown. Statistical significance was determined using a two-way ANOVA with Bonferroni test. d FER siRNA 2 and 3 have variable effects on migration: At 24 h post transfection, siNEG, siFER2, and siFER3-transfected MDA-MB-231 cells were seeded onto the upper part of a transwell chamber in serum-free medium, and allowed to migrate towards serum for 24 h. Cells that had migrated to the underside of the transwell membrane ('Membrane'), and cells that had migrated through the membrane entirely and attached to the bottom of the well ('Through migration') were fixed and stained with crystal violet and quantified using an Odyssey scanner. Quantification of migration was first normalized to cell proliferation (shown in graph on right), for each cell type. Data are shown as percentage migration, of membrane or 'through' migration, with siNEG total cell migration set as 100%. Images of the transwell membrane-and 'through'-migrated cells are shown, n = 1 of three experiments with similar results. e siRNA3-transfected cells have decreased cell adhesion to fibronectin, whereas FER siRNA 2 does not affect adhesion: MDA-MB-231 cells were seeded onto fibronectin (FN; 5 μg/ml) or collagen I (Col; 10 μg/ml)-coated wells, 48 h post transfection with siNEG or siFER2 or 3. Cells were fixed and stained with crystal violet 20, 40, or 60 min later. Quantification of adherent cells was measured using Odyssey scanning and densitometry. Data are presented as fold-change of adhesion of siNEG cells, from three independent experiments, statistical analysis was performed using the Student's t-test siFER3 disrupts the formation of mature cell adhesions and functional lamellipodia necessary for directional cell migration.
As siRNAs targeting FER apparently have different effects on cell morphology we also tested whether suppressing a well-described substrate of FER; cortical actin (cortactin, which has a role in both biosynthetic and recycling trafficking pathways [29] [30] [31] ) had any effect on IGF-1R expression levels. We observed that the IGF-1R colocalizes with cortactin at sites of cell adhesion in MCF-7 cells (Fig. 5d) . SiRNA-mediated suppression of cortactin reduced IGF-1R levels in both MCF-7 and MDA-MB-231 cells (Fig. 5e, f) . This could be prevented by proteasome inhibition (shown for MDA-MB-231 cells in Fig. 5f ).
To further test whether cell adhesion is required for FERenhanced IGF-1R activity we compared the effects of FER on IGF-1R autophosphorylation and signaling in HEK293T cells that were adherent or maintained in suspension. We observed that the FER-enhanced phosphorylation of IGF-1R/WT and IGF-1R/KD on Y1131 was completely abolished when cells were not allowed to adhere (Fig. 5g) . As expected, the phosphorylation of SHC and FAK, evident in adherent cells expressing IGF-1R/WT and FER/WT, was absent in non-adherent cells (Fig. 5g) . Phosphorylation on the Y1135/1136 site was reduced by lack of adhesion, but in agreement with results in Fig. 2 , was not affected by FER. Interestingly, the effects of lack of cell adhesion on IGF-1R were accompanied by a reduction in FER autophosphorylation (Fig. 5h) . This demonstrates that adhesion signals enhance FER activity and its potentiation of IGF-1R and SHC/ERK1/2 phosphorylation.
These observations suggest that FER promotes the assembly of mature cell adhesions, which enhances the phosphorylation and activity of the IGF-1R.
FER expression strongly correlates with EMT markers in mesenchymal-like breast cancer, and its activity can be suppressed by an ALK kinase inhibitor FER expression was previously associated with a poor outcome in triple-negative breast cancer [28] . We explored whether this may be related to FER function in enhancing IGF-1R and adhesion signaling in breast cancer by first analyzing available data sets from breast tumors and cell lines. Kaplan-Meier (KM) survival plots derived from The Cancer Genome Atlas (TCGA) data [32] demonstrated that high expression of FER is associated with poor relapse-free survival among breast cancer patients (P = 0.00015; n = 3951; Fig. 6a, Fig. S4A ). Following exclusion of systemically untreated patients, the hazard ratio (HR) rose to 1.63, whereas the median survival almost halved with high FER expression (65.1-34.82 months; P = 0.91 × 10 Cells of these subtypes have been described as lessdifferentiated and to manifest a highly migratory/invasive phenotype [33] . Interestingly, IGF-1R activity in tumors has also been associated with a mesenchymal and stem-like phenotype of cancer cells [7, 33] . In line with these observations, analysis of RNA-Seq expression profiles of 82 breast cancer cell lines extracted from the study of Marcotte et al. [34] demonstrated that migratory and mesenchymal breast cancer cell lines express FER at significantly higher levels than luminal cell lines (P < 0.0001; Fig. 6b, Fig. S4C ). Expression of FER was also strongly correlated with expression of EMT markers, including ZEB1/2, TWIST1/2, SNAI2 (SLUG) and VIM (Pearson R~0.4, P < 0.0003; Fig. 6c, S9 ). We also investigated whether FER expression correlates with these markers in patient samples using TCGA) RNA-Seq data from 1215 breast cancer patients. We found that FER expression strongly correlated with ZEB1/2 (Pearson R: 0.6), TWIST1 and SNAI2 and other EMT markers (Fig. S4 B-E) .
We also determined that FER expression in a panel of breast cancer cell lines could be positively correlated with phosphorylation of SHC (P-Y239/Y240) ( Fig. 6d; S4F) , noting that several of these cell lines expressed the p66 isoform of SHC that is associated with REDOX stress and more recently with coupling mechanical signals to activation of RhoA [35] . (The analysis of RNA sequencing (RNA-Seq) and reverse phase protein array (RPPA) data from 95 breast cancer patients, available from TCGA, further demonstrated a positive correlation in phosphorylation of SHC (P-Y317; Pearson R: 0.34; P = 0.0008) and SRC (P-Y416; Pearson R: 0.27; P = 0.007) and expression of FER (Fig. S4G) .
All of the in silico analyses suggested an important function for FER in breast cancer aggressiveness. Therefore, we next sought to test the consequences of pharmacological inhibition of FER in breast cancer cells. As there is no specific FER kinase inhibitor available, we opted to test an inhibitor of the two anaplastic lymphoma kinase (ALK), AP26113 (Brigatinib). This compound potently inhibits FER in in vitro kinase assays and was described to have FER as its next most selective target following ALK [36] . A similar ALK inhibitor has been reported to inhibit FES kinase, which is structurally similar to FER [37] (Fig.  S4H ).
First, we tested AP26113 over a range of concentrations (50-500 nM) in HEK293T cells overexpressing FER (Fig.  6e ). Concentrations as low as 50 nM, decreased FER autophosphorylation on Y402 by~80% and also reduced FER-mediated phosphorylation of Y1131 in the IGF-1R. Consistent with our findings (Fig. 2 ) the inhibitor did not alter phosphorylation of Y1135/1136 in the IGF-1R (Fig.  6e) . Moreover, this kinase inhibitor suppressed phosphorylation of SHC and ERK1/2. This indicates that AP26113 inhibits FER kinase activity and FER-induced signaling.
We also tested AP26113 on breast cancers cells that express endogenous levels of FER. HS578T cells were chosen for these studies as a mesenchymal-like/highly migratory breast cancer cell line with relatively high FER levels [38] (Fig. 6d) . Exposure of HS578T cells to AP26113 (100-500 nM) resulted in inhibition of FER kinase autophosphorylation (Fig. 6f) . Interestingly, FER levels were also suppressed. This may be due to destabilization of inactive FER as was previously reported [30] . AP26113 also reduced phosphorylation of SHC, SRC, and ERK1/2, without affecting AKT phosphorylation. Phosphorylation of the IGF-1R on Y950 and 1131 could not be detected in these cells probably because of the reduction in IGF-1R levels. We also asked whether AP26113 (0.5 µM) altered the motility of HS578T cells over 15 h in wound healing assays. We observed consistently impaired ability to fill the wound in the presence of AP26113 (Fig. 6g) , and again, the drug reduced FER expression levels and phosphorylation, as well IGF-1R expression (Fig. 6h) . Taken together, these data indicate that FER kinase activity and its actions in enhancing signaling pathways can be pharmacologically inhibited by the AP26113 inhibitor. This inhibitor is currently being tested in phase 2 clinical trials as a therapy for non-small cell lung cancer (ID:NCT02706626). Fig. 6 High FER expression in mesenchymal breast cancer negatively correlates with relapse-free survival. Pharmacological inhibition of FER kinase abolishes its signaling. a Kaplan-Meier plots were drawn using data accessed through KM plotter, a publicly accessible interface for TGCA survival data. All data sets were assayed using probe ID: 206412. P-value, hazard ratio (HR) and median survival were calculated and are displayed. b RNA-Seq analysis of FER mRNA expression compared in low and highly migratory or luminal, basal A, and mesenchymal (basal B) breast cancer cell lines (n = 78), extracted from Marcotte et al. (2016) . FER mRNA expression is plotted on a log2 scale. c table representing in situ analysis of correlation of FER and expression of several mesenchymal genes in breast cancer cell lines (n = 82), extracted from Marcotte et al. 2016 . d Western blotting analysis of FER protein expression and phosphorylation of SHC in a panel of breast cancer cell lines. e Western blotting analysis of effects of FER-i (AP26113) on IGF-1R/WT and EV or FER-co-expressing HEK293T cells. At 48 h post transfection cells were cultured with AP26113 (0-500 nM) for 2 h, subsequently lyzed and immunoblotted for the indicated phospho-and total protein levels. FER immunoblot was included as an overexpression control. f Western blotting analysis of effects of FER-i (AP26113) on endogenous FER and signaling in HS578T cells. Cells were treated for 2 h with 0-2 μM, subsequently lyzed and immunoblotted for the indicated phospho-and total protein levels. g, h Effects of FER-i on HS578T cell migration were assessed by wound-healing assays as described in methods. Cell were pretreated with AP26113 prior to wounding and maintained in medium containing 0.5 µM inhibitor for 15 h post-wounding. Cells were photographed with at 10 × magnification and the images represents one of three independent experiments with similar results. After 15 h of exposure to AP26113 cells were lyzed and western blots prepared to assess levels of Y402 FER, total FER and IGF-1R h
Discussion
Cooperative IGF-1R and adhesion signaling has been proposed to facilitate cancer progression [2, 5, 39] . Here, we demonstrate that the non-receptor tyrosine kinase FER can regulate IGF-1R expression levels, activity, and adhesiondependent signaling. FER has been reported to play a role in cross-talk between different receptor systems including cell-cell and cell-matrix complexes [19, 20] . Our findings (summarized in the model in Fig. 7 ) indicate that FER acts as an important node in such cross-talk between Integrin and IGF-1R signaling and that FER can be reciprocally activated by both IGF-1 and adhesion signaling.
Here, we show that FER and the IGF-1R strongly colocalize in cells, an interaction that does not require either FER or IGF-1R kinase activity. However, this interaction is essential for FER-enhanced IGF-1R phosphorylation and signaling. FER-induced phosphorylation of IGF-1R requires cell adhesion signals. It has been reported that FER regulates cellular distribution of Integrins by downregulating surface expression of α6 and β1 Integrins [20] . Cooperation of growth factor receptors with different integrin heterodimers may positively or negatively impact growth factor activation and signaling [40] . Hence, the modulation of surface expression of different Integrin subunits can alter the growth factor signal. FER could facilitate IGF-1R association with Integrin-adhesion complexes, thus enhancing its phosphorylation and signaling output. We observed that FER generally promotes autophosphorylation of adhesion-associated kinases, SRC and FAK, and these can, in turn, directly phosphorylate IGF-1R, when activated by Integrin-mediated cell adhesion.
Although the role of FER in growth factor signaling has been previously documented [21, 22, 24] , this is the first report of FER enhancing the expression levels and activity of the IGF-1R. FAK suppression has also been reported to decrease IGF-1R steady state levels [12, 16] , again indicating that adhesion complexes support IGF-1R expression. The stability of other growth factor receptors can also be enhanced by adhesion complexes. For example, c-MET stability has been demonstrated to be dependent on Tensin-4, an adapter that links Integrins to β actin [41] . Therefore, we propose that the recruitment or localization of the IGF-1R to sites of cell adhesions results in enhanced IGF-1R stability. This could be mediated by the F-BAR domain of FER, because its oligomerization facilitates the formation of Fig. 7 Schematic representing the role of FER in potentiation of cooperative signaling between IGF-1R/β1 Integrin at sites of cell adhesion. We propose that the non-receptor tyrosine kinase FER is an important signaling node in cooperative signaling between the IGF-1R and cell adhesion signaling. FER-IGF-1R axis has a direct effect on IGF-1R steady state levels, its phosphorylation and signaling output. (CTN -cortactin) lamellipodia [42, 43] . We observed that suppression of cortactin, a substrate of FER, reduced IGF-1R steady state levels. Cortactin has been previously documented to prevent ligand-induced EGFR degradation and to enhance β2 adrenergic receptor (β2AR) recycling [29, 44] . On the other hand, FER suppression was reported to accelerate EGFR internalization [23] . Therefore, FER and adhesion-mediated stability of IGF-1R could be achieved by either decreased internalization, cortactin-mediated recycling, or decreased IGF-1R proteostasis during biosynthesis. It is possible that the effects of FER on enhancing IGF-1R expression by regulating proteostasis could be mediated by FER altering the glycosylation of the IGF-1R receptor, because FER has been demonstrated to regulate laminin-binding glycan [45] . Indeed, impaired regulation of IGF-1R proteostasis associated with loss of the tumor suppressor protein AIRAPL has recently been associated with myeloid cell transformation and leukemia [46] . The FES protein, which is closely related to FER, has also been associated with acute myeloid leukemia where it can be activated by FLT3 [18] to promote cell survival. It is interesting to speculate that FES may mediate some of its survival functions in myeloid leukemia by enhancing the expression or activity of the IGF-1R. This however remains to be tested.
An unexpected finding of our study was that siRNAmediated suppression of FER using different oligonucleotides consistently reduced FER expression to apparently similar levels while causing consistently different effects on cell morphology and migratory potential. Our study and that of Ivanova et al. [20] analyzed FER suppression in the MDA-MB-231 breast cancer cell line, which displays a mesenchymal phenotype. We noted that FER suppression with siFER2 in our study produced a similar phenotype to that described by Ivanova et al., with cells becoming more spread and less migratory. However, other siRNAs, in particular siFER3, which we also studied in detail, produced different effects on cell morphology and migration. Interestingly, the different siRNAs produced consistently similar effects on cell morphology in different cell lines, which suggests they selectively target certain isoforms or complexes of FER. We could not establish whether different isoforms were implicated because we only observed changes in one protein with the available antibody. However, our data and previous reports on FER function in cell adhesion complexes indicate that the alterations in cell morphology elicited by siFER2 and siFER3 are both consistent with disrupting the formation of lammelipodia. One predicted outcome is that cells would become more spread with weak adhesions and lack of directional lamellipodia (observed with siFER2) and a second is that cells may not properly form lamellipodia (observed with siFER3). An additional possibility, suggested by the high levels of p66SHC observed in breast cancer cell lines that also express FER highly, is that p66SHC-mediated activation of the RhoA pathway in fillopodia [35] may be affected by FER suppression. Overall, our observations illustrate that the use of selective siRNAs or shRNAs to investigate the physiological responses to FER suppression is not entirely straightforward.
A previous report demonstrated that that FER expression is associated with aggressive breast cancer in patients (n = 485) and inversely correlates with progression-free survival of ovarian cancer patients [24] [20] . Here, we analyzed a large subset of TCGA clinical survival data, which also shows that high FER expression (by RNA-Seq) correlates with poor relapse-free survival in breast cancer patients (n = 3951). High expression of FER particularly increases the HR in the mesenchymal-subtype cohort of breast cancer patients (HR: 4.31). In support of this, we observed that mesenchymal/highly migratory breast cancer cells express FER at significantly higher level than their counterparts. Considering the strong effects of ectopic FER expression on IGF-1R phosphorylation, we propose that FER could mediate potentiation of IGF-1 signaling, particularly in cancers with an EMT or stem-like phenotype. This is consistent with the observation that IGF-1R expression and activation may be elevated in breast cancer stem cells [33] . IGF-1R activity has also been implicated in the self-renewal of lung adenocarcinoma and chemoresistant colon cancer stem cells [33] , and may also facilitate the EMT transition of breast, colon, prostate and lung cancer cells [2, 12, 47, 48] .
As described here and elsewhere, the role of FER in supporting an invasive phenotype highlights the need to develop specific FER kinase inhibitors. Our results lead us to propose that AP26113, which inhibits FER kinase and signaling at nanomolar concentration, is an excellent candidate. AP26113 was developed as an ALK inhibitor and is in clinical trials phase 2 for non-small cell lung cancer (Brigatinib; ID: NCT02706626). TAE684, a similar ALK inhibitor has been reported recently to target FES that possesses a kinase domain highly homologous to FER [37] . Importantly, we observed that the residues required for interaction between TAE684 and FES kinase, that were identified by X-ray crystallography [37] , are conserved in FER kinase. Inhibition of FER using AP26113 may present a useful therapeutic approach for mesenchymal-type breast cancers. In support of this concept, a tyrosine kinase inhibitor, PKC412 that was shown to specifically target a panel of post-EMT breast cancer cells mainly acts through inhibition of SYK and FER [49] .
The ability of FER to mediate adhesion-enhanced phosphorylation of catalytically active or inactive IGF-1R in the presence of IGF-1R TKI (data not shown) could also provide a mechanistic explanation for the lack of efficacy of IGF-1R TKIs in the clinic. This conclusion is supported by reports that co-targeting the IGF-1R with SRC and FAK in breast, lung, and pancreatic cancer models can synergistically decrease tumor growth [12, 14, 50] . Thus, co-targeting IGF-1R and adhesion signaling could improve the efficacy of IGF-1R inhibitors. We also propose that FER is a potential biomarker for adhesion-enhanced IGF-1R activity and its inhibition by AP26113 could effectively target tumor cells that are addicted to cooperative IGF-1R and adhesion signaling.
Materials and methods
Cell culture and IGF-1 stimulation MCF-7, MDA-MB-231, MDA-MB-157, HEK293T, R −/IGF-1R/WT ( + 1.5 μg/ml puromycin), Hs578T, R− and R + cells were maintained in Dulbecco's Modified Eagles Medium (DMEM). MDA-MB-436 cells were cultured in a 50/50 mix of Leibovitz L15/RPMI media, and CAL51 cells in a 50/50 mix of DMEM/Hams Nutrient F12 media. HCC1806, ZR-75-1 and HCC70 cells were maintained in RPMI 1640. BT-549 cells were grown in RPMI 1640 with 0.023IU/ml Insulin. All media were supplemented with 10% (v/v) heat inactivated fetal bovine serum, 10 mM LGlutamine, and 5 mg/ml penicillin/streptomycin. MCF10A cells were cultured as previously described [51] . Cells were cultured at 37°C in a humidified atmosphere at 5% CO 2 . All cells were determined to be free of mycoplasma.
For analysis of non-adherent (suspension) cells, cells were plated in duplicate on 10 cm plates and cultured overnight in complete medium. Cells from one plate of each cell type enzymatically detached for 5 min, and cells recovered by centrifugation (1000 RPM) for 5 min. Cells were then washed with PBS and re-suspended in complete medium (10 ml) in a 50 ml tube with occasional rotation for a total of 4 h prior to harvesting for lysis.
For analysis of IGF-1 stimulation responses, cells were cultured at seeding densities that allowed for an~70% confluency after 20 h. Cells were incubated in serum-free medium for 4 h prior to stimulation with 10 ng/ml IGF-1 where appropriate. To terminate stimulation, cells were placed on ice and washed immediately with ice-cold PBS.
Immunofluorescence and PLA and microscopy Cells were seeded on serum-coated 10 mm glass coverslips, washed with phosphate-buffered saline, fixed with 4% paraformaldehyde in PHEM buffer for 30 min at 37°C, quenched with 50 mM Ammonium Chloride for 15 min, and permeabilized using 0.1% Triton/PHEM for 5 min.
Cells were then blocked for 30 min using 5% donkey serum/PHEM, incubated for 1 h with the indicated primary antibodies diluted 1:100 (unless specifically stated otherwise in figure legends) in the blocking buffer and washed with PHEM buffer. This was followed by incubation with Alexa488-(1:200) or Cy3-(1:1000) conjugated secondary antibodies with Hoechst.
For Duolink PLA (Sigma Aldrich) experiments, cells were fixed, quenched, and permeabilized exactly in the same manner as for the standard immunofluorescence. Following this, cells were incubated with Duolink-blocking buffer in a pre-heated humidity chamber for 30 min at + 37°C. Primary antibodies anti-IGF-1R (#3027 (1:200) or #9750 (1:100); Cell Signalling) and anti-FER (#4268 (1:200) ; Cell Signalling), were diluted in the Duolinkblocking buffer and incubated on the cells in a humidity chamber overnight. PLA anti-rabbit plus and anti-mouse minus probes were used to label primary antibodies. The probes were diluted 1:5 in a blocking buffer and slides were incubated in a pre-heated humidity chamber for 1 h at + 37°C. The ligation stock (1:5) with ligase (1:40) was added to the coverslips for 30 min at + 37°C. The amplification stock (1:5) with polymerase (1:80) was added to coverslips for 100 min. The solution was removed and coverslips dried at room temperature in the dark before mounting on slides using a minimal volume of Duolink In Situ Mounting Medium with DAPI.
Images were acquired using a SPOT charge-coupled device camera mounted on a Nikon T600 fluorescent microscope (Kingston Upon Thames, UK). For confocal microscopy, images were acquired using a Flouview FV1000 confocal laser scanning microscope (numerical aperture:1.4) with a × 60 oil or × 100 oil-immersion objective. Maximum intensity projections and z-stacks were processed and analyzed in Olympus Fluoview (FV10-ASW 4.0 Viewer) where brightness and contrast were adjusted.
SDS-PAGE and western blotting
Cellular protein extracts were prepared with a lysis buffer (NP-40 as described previously [5] ) for 30 min on ice. Protein concentrations were determined via Bradford Assay, and samples were then either denatured by boiling for 5 min in 5 × loading buffer (2% w/v SDS, 8% v/v glycerol, 60 mM Tris-HCL, pH 6.8, 1.2% β-mercaptoethanol, and 0.2-0.4% Bromophenol Blue), or carried through to immunoprecipitation studies. Proteins were resolved by 4-20% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were transferred to nitrocellulose membrane and blocked for 1 h at room temperature in 5% milk in Tris-buffered saline-T (20 mM Tris, 150 mM NaCl and 0.05% Tween 20, pH 7.6). Primary antibodies were diluted in 5% milk in Tris-buffered saline-T and incubated with membranes at 4°C overnight. IRDYEconjugated secondary antibodies were used for detection with the Odyssey Image Scanner System (LI-COR Biosciences) and the Odyssey quantification software. Where reprobes were necessary, membranes were incubated with stripping buffer (200 mM NaOH, 1 % SDS) for 20 min at room temperature. Membranes were then washed, blocked, and incubated with appropriate antibodies.
Immunoprecipitation
Cell lysates were pre-cleared using Protein G-Agarose beads with lysis buffer and inhibitors for 1 hat 4°C at a rotor speed of 5 RPM, and were then recovered by centrifugation at 3000 RPM for 3 min at 4°C. Primary antibodies were incubated at 4°C for 1 h. Immune complexes were obtained by adding 25 µl of pre-washed Protein GAgarose beads for 1 h at 4°C, and then recovered by centrifugation at 1000 RPM for 3 min at 4°C. Immunoprecipitates were washed three times with ice-cold lysis buffer followed by centrifugation. In total, 2 × loading buffer was added to each sample prior to boiling for 5 min. Samples were separated by SDS-PAGE as described above.
DNA transfection and mutagenesis
Cells were transiently transfected with pcDNA3 plasmids encoding WT or mutant IGF-1R (IGF-1R/KD: K1003R) and pSG5 plasmids encoding FER kinase or kinase-dead FER Kinase (D743R; KD) or SH2-domain mutant (R483Q; SH2). The corresponding empty vector was transfected for each plasmid as control. Mutagenesis of pSG5 plasmid to introduce D743R (FER/KD and R483Q (FER/SH2) was carried out using the QuikChange Lightning site-directed mutagenesis kit (Agilent, #210518).
For transfection of R− cells, cells were seeded at a density of 1.5 × 10 6 cells/10 cm tissue culture dish, in antibiotic-free medium. Eighteen hours later, cells were transfected with relevant DNA (10 µg) and Lipofectamine 2000 (diluted in OptiMem) per 10 cm tissue culture dish and then incubated at 37°C overnight. Transfected R− cells were subsequently split in preparation for experiments to be carried out 48 h after transfection. MCF-7 and MDA-MB-231 cells were transfected in a similar manner to R− cells, except for: seeding at 1.2 × 10 6 cells/10 cm and the use of Lipofectamine; For co-transfection of IGF-1R and FER in HEK 293-T cells; cells were transfected using Calcium Phosphate. In brief, cells were seeded 5 h prior to transfection at a confluency of 70%. The pSG5 vector encoding FER (3 µg) together with 1 µg of pcDNA3 IGF-1R expressing plasmids was added to CaCl2. The DNA/ CaCl 2 mixture was then added dropwise to 2 × HBSS at a ratio of 1:1. Samples were allowed to stand for 1-2 min after which the solution was distributed to the pre-seeded cells. Cells were then cultured overnight and then re-seeded for experiments and lysed 24 h later.
siRNA transfection
A non-targeting oligonucleotide, Silencer Negative siRNA Control #2 (AM4311) from Ambion (Cambridgeshire, UK) was used as a Negative Control. Individual oligos targeting human FER kinase: siFER2 (S100287756; CAGATA-GATCCTAGTACAGAA) and siFER3 (S102622067; 5′-CAGAACAACTTAGTAGGATAA-3′ were obtained from Qiagen. Sequences for the other FER siRNAs from Qiagen tested are listed in Supplementary Table 1 , as well as those of the SMARTpool ON-TARGETplus FER siRNA (L-003129-00-0005), which was purchased from Dharmacon. Transfections were performed using a final concentration of 20 nM siRNA, except where otherwise noted, using RNAiMAX, according to the manufacturer's recommendations. In brief, cells were trypsinized and re-suspended in antibiotic-free culture media with serum. siRNA oligonucleotides were diluted in OptiMem media. RNAiMAX transfection reagent was added to the siRNA solutions. siRNA/RNAiMAX complex was pipetted to six-well plate and 6.5-8.5 × 10 5 cells per well were then added. Cells were allowed to adhere overnight to the tissue culture plate. 24 h post transfection, the siRNA/RNAiMAX complex was removed and cells were re-seeded for experiments.
Cell proliferation, migration, and adhesion assays Proliferation Cells were transfected as described above and re-seeded in triplicate at 24 h post transfection (3.0 × 10 4 cells/well) in 24-well plates. Cells were collected every 24 h up to 96 h. Media was removed, cells were washed once with PBS and fixed with 96% Ethanol for 10 mins, followed by staining with 0.05% crystal violet in 20% Ethanol for 30 min. Staining was assessed using an Odyssey Scanner and quantified using Licor Image studio Lite software (LI-COR Biosciences).
Migration; wound-healing assay HS578T cells were seeded in six-well plates at a concentration of 3.5 × 10 5 cells/ml 24 h prior to wounding. The monolayer was scratched using a sterile P10 tip (Time 0 h). Cells were allowed to migrate for 15 h and photographed using a 10 × objective at Time 0 h and 15 h.
Migration; transwell assay
Migration assays were performed using 6.5 mm transwell inserts with 8.0 µm membrane (costar#3422; Cambridge, MA), according to the manufacturer's recommendations. In brief, 24 h post transfection with siNEG, siFER2, or siFER3 siRNAs, 2 × 10 5 MDA-MB-231 cells were seeded onto the upper part of the transwell chamber in serum-free medium, and allowed to migrate toward 10% serum in the lower well of the chamber for 24 h. Cells were also added to two additional wells without transwells to serve as cell proliferation controls. These controls, cells that had migrated to the underside of the transwell membrane ("Membrane"), and cells that had migrated through the membrane entirely and attached to the bottom of the well ("Through migration") were fixed and stained with 0.05% crystal violet and scanned using the Odyssey scanner.
Adhesion assay
The wells of a 96-well plate were coated with 100 μl of fibronectin (Sigma, UK; 5 μg/ml) or collagen I (Gibco, Lifetechnologies, Grand Island, NY; 10 μg/ml) for 2 h at 37 o C, The plates were washed and blocked with 100 μl of 2.5% bovine serum albumin/well for 1 h before further washing with PBS. Cells (100 μl containing 5 × 10 4 cells) were added to each coated well in triplicate and allowed to attach for the indicated times. The medium was removed, and attached cells were fixed with Methanol and stained with 0.05% Crystal Violet, scanned and quantified as described above.
RNA isolation and quantitative RT-PCR
Total RNA was isolated using the Trizol method and cDNA synthesis was carried out by reverse transcription with equal amounts of RNA (2 μg) using a cDNA synthesis kit (Invitrogen). Quantitative PCR was carried out using the LightCycler instrument; Roche Molecular Biochemicals (East Sussex, UK) with QuantiTect SYBR Green technology (Qiagen, Crawley, West Sussex, UK) using the following primers:
(1) IGF-1R: Forward: 5′-ATGTCCAGGCCAAAACAGGAT-3′;
Reverse: 5′-CCTCCCACTCATCAGGAACG-3′ (2) FER: Forward: 5′-GCTTCAGAAACGGCCATCAC-3′;
Reverse: 5′-AGCGTCTCCATGATGAGGTG-3′. The delta-delta CT method was used to analyze data and determine relative mRNA expression levels.
Bioinformatics analysis
TCGA RNA-Seq data (n = 1215) was accessed from the MD-Anderson Standardized data browser (bioinformatics.
mdanderson.org/cancer/databrowser/). Correlation of gene expression was calculated using Pearson's product moment correlation coefficient (r), statistical significance was determined using a modified t-test (P).
To determine correlation between protein levels and RNA levels in breast cancer, an RPPA dataset was downloaded, TCGA patient sample ID's were then aligned to the RNA-Seq matrix to ensure each pair corresponded to two different assays conducted on the same primary sample. Correlation was then calculated as for RNA-Seq analysis (n = 95).RNA-Seq data for an extended panel of breast cancer cell lines was obtained from the supplementary material of Marcotte et al. [34] .
KM plotter analysis
The KM Plotter online survival analysis was used to generate KM plots [32] . Gene expression data and relapsefree and overall survival information are downloaded from GEO (Gene Expression Omnibus; Affymetrix microarrays only), EGA, and TCGA. Patient samples were split into two groups according to median expression of FER (ID: 206412). The two patient cohorts are compared by a KM survival plot, and the HR with 95% confidence intervals, median survival and log-rank P-value are calculated.
Statistical analysis and densitometry
Densitometry of western blots was carried out by measuring the intensity of immunolabelled protein bands using Odyssey/Image Studio Light Software. Results were expressed as ratio of phospho:total protein, or where relevant as ratios to total loading controls. In order to simultaneously investigate several IGF-1R phosphorylation sites, and FER/phospho-FER levels, technical replicates of lysates were run in parallel on the same or separate blots. To ensure consistent protein loading, each blot was probed with a loading control (e.g., actin, tubulin, GAPDH or pansignaling proteins such as AKT, ERK1/2, or SHC), one of which was included in each figure dataset as a representative of protein loading for those samples. For data analysis of protein expression however, the respective protein loading control for each sample on a particular blot was used for normalization of protein expression. Changes in ratio of phospho/pan-protein levels were expressed as fold changes relative to the untreated control. Statistical significance was determined using Student's t-test using Microsoft Excel or GraphPad Prism. Significance was classified as a P-value of * < 0.05, ** < 0.01, *** < 0.001. Where specified, one-or two-way analysis of variance (GraphPad Prism) was used to determine significance, were a P-value of < 0.05 was deemed significant. All graphs were produced using GraphPad Prism and are graphed using standard error of the mean.
